HPV16 E5 Mediates Resistance to PD-L1 Blockade and can be targeted with Rimantadine in Head and Neck Cancer.
暂无分享,去创建一个
J. Califano | E. Cohen | A. Venuti | A. Sharabi | P. Sanders | Sangwoo Kim | S. Miyauchi | F. Paolini | K. Guram | J. Gutkind | E. Cohen